Patient consent is potentially tricky for pharma R&D to navigate as a result of new data protection rules in Europe.
Laura Barrell
Advertisement
Laura Barrell is a specialist Pharmaceuticals and Life Sciences lawyer at VWV, [email protected].
Articles by Laura Barrell
Advertisement
Latest Updated Articles
- Dual Aspects of Informed vs. Explicit Consent in R&D
July 10th 2019
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5